Avid Bioservices Competitors and Similar CompaniesClear all
Durect's competitors and similar companies include Sucampo Pharmaceuticals and BTG.
 Durect DURECT is a specialty pharmaceutical company developing innovative drugs for pain and chronic diseases. |  Sucampo Pharmaceuticals Sucampo is a global biopharmaceutical company focused on the development and commercialization of medicines based on prostones, to meet the major unmet medical needs of patients on a global basis. | ||
Founding Date | Founding Date N/A | Founding Date 1996 | Founding Date 1948 |
Type | Type Public | Type Subsidiary | Type Subsidiary |
Tags | |||
Locations | Locations Cupertino, US HQ | Locations Rockville, US HQ Chiyoda, JP Chuo Ward, JP Kita Ward, JP Sanda Shi, JP Zug, CH Milton, GB | |
Employees | Employees 902% increase | Employees 37 | Employees 650 |
Financial | |||
Revenue (est.) | Revenue (est.) $2m (FY, 2024) | Revenue (est.) $230.1m (FY, 2016) | Revenue (est.) £731.3m (FY, 2019) |
Cost of goods | Cost of goods $78k (FY, 2024) | Cost of goods $76m (FY, 2016) | Cost of goods £221m (FY, 2019) |
Gross profit | Gross profit $2m (FY, 2024) | Gross profit $154.1m (FY, 2016) | Gross profit £510.3m (FY, 2019) |
Net income | Net income ($8.3m) (FY, 2024) | Net income $18.5m (FY, 2016) | Net income £88.3m (FY, 2019) |
For sources of this data, please see the company profile
View Company Profiles
Sucampo Pharmaceuticals
HQ
Rockville, US
Sucampo is a global biopharmaceutical company focused on the development and commercialization of medicines based on prostones, to meet the major unmet medical needs of patients on a global basis.
View company